Clinical Trials Directory

Trials / Unknown

UnknownNCT03559322

Real World Experiences of the iNAP® Lite in OSA Adults in Taiwan

A Prospective, Observational, Post-market Surveillance Study to Evaluate the Long-term Safety and Efficacy of the iNAP® Sleep Therapy System in Adults With Obstructive Sleep Apnea

Status
Unknown
Phase
Study type
Observational
Enrollment
76 (estimated)
Sponsor
Somnics, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A Prospective, Observational, Post-market Surveillance Study to Evaluate the Long-term Safety and Efficacy of the iNAP® Lite Sleep Therapy System in Adults with Obstructive Sleep Apnea

Detailed description

Obstructive sleep apnea (OSA) impacts sleep quality of patients, which contributes significantly to hypertension, stroke, myocardial infarction and other health problems. Intraoral devices, such as tongue retaining devices, palatal lifting devices and mandibular repositioning devices designed to increase the patency of the airway and to decrease airway obstruction, are used to treat OSA. To this end, we are conducting a prospective, observational, post-market surveillance study to evaluate the long-term safety and efficacy of the iNAP® Lite sleep therapy system (iNAP® Lite), a tongue and soft palate retaining intraoral device, in adults with OSA.

Conditions

Interventions

TypeNameDescription
DEVICEiNAP® Lite Sleep Therapy SystemClass II intraoral devices for snoring and/or obstructive sleep apnea

Timeline

Start date
2019-08-01
Primary completion
2021-08-01
Completion
2021-12-30
First posted
2018-06-18
Last updated
2019-09-23

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03559322. Inclusion in this directory is not an endorsement.